• Editors-in-Chief

    Graham Packham, PhD

    Professor of Molecular Oncology, University of Southampton, Southampton, UK
    Email: G.K.Packham@soton.ac.uk

    Nicola Normanno, MD

    Chief of Cell Biology and Biotherapy Unit, Director of Translational Research Department, Istituto Nazionale Tumori "Fondazione Pascale" Via Mariano Semmola, Naples, Italy
    Email: nicnorm@yahoo.com
    Associate Editors

    Giuseppe Curigliano, MD, PhD

    Interests: breast cancerl; early drug development; precision oncology; biomarkers; NGS
    Associate Professor of Medical Oncology, University of Milan; Head, Division of Early Drug Development, European Institute of Oncology, Milan, Italy

    Gennaro Daniele, MD, PhD

    Interests: drug development; clinical trials; translational research; gynecologic malignancies; biomarkers
    Scientific Director, Clinical Trials Center, Agostino Gemelli University Policlinic, Rome, Italy

    Jianxun Ding, PhD

    Interests: polymer chemistry; biomaterial; controlled drug delivery; immunotherapy; regenerative medicine
    Associate Professor, Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China

    Alan L. Epstein, MD, PhD

    Interests: cancer immunotherapy; antibody targeting; tumor antigens; CAR T-cell therapy; tumor models
    Professor of Pathology, Department of Pathology, University of Southern California, Los Angeles, USA

    A. Ganesan, PhD

    Interests: medicinal chemistry; chemical biology; organic synthesis; epigenetics; natural products
    Professor in Chemical Biology, School of Pharmacy, University of East Anglia, Norwich, UK

    Marius Ilie, MD, PhD

    Interests: pathology; lung cancer; biomarkers; liquid biopsy; precision pathology
    Professor of Pathology, Université Côte d'Azur; Surgical Pathologist, Nice University Hospital, Nice, France

    Nagesh Kalakonda, PhD

    Interests: B-cell malignancies; clinical trials; drug therapy and signalling
    Reader and Honorary Consultant, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK

    Simon Langdon, MA, PhD

    Interests: ovarian cancer; breast cancer; estrogen signaling; HER signaling; DNA repair
    Reader, School of Medicine, University of Edinburgh, Edinburgh, UK

    Wan-Liang Lu, PhD

    Interests: resistant cancer; cancer stem cells; gene regulation; nanomaterials; liposomes
    Professor and Vice Dean, School of Pharmaceutical Sciences, Peking University, China

    Erika Martinelli, MD, PhD

    Interests: colorectal cancer; translational research; resistance to targeted therapies; gastrointestinal cancer
    Associate Professor in Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania L. Vanvitelli, Naples, Italy

    Alessandro Morabito, MD

    Interests: lung cancer; target based agents; angiogenesis inhibitors; immunotherapy; clinical trials
    Director of Thoracic Medical Oncology, Istituto Nazionale Tumori "Fondazione Pascale" Via Mariano Semmola, Naples, Italy

    David Rizzieri, MD

    Interests: stem cell transplant; cellular therapy and CAR-T; leukemia; lymphoma; clinical trials
    Professor of Medicine, Duke University Medical Center; Chief, Section of Hematologic Malignancies, Duke Cancer Institute, Durham, USA

    Gautam Sethi, PhD

    Interests: signal transduction; apoptosis; transcription factors; metastasis; mouse models of cancer
    Associate Professor, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    Valerie Speirs, PhD

    Interests: oestrogen receptor biology; endocrine resistant breast cancer; male breast cancer; in vitro models; biomarker
    Professor and Chair in Molecular Oncology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
    Editorial Board Members

    Luca Agnelli, PhD

    Interests: lymphoid malignancies; bioinformatics and biostatistics in cancer; -omics analyses; NGS; non-coding RNA
    Post-doc, Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy

    Rossana Berardi, MD

    Professor in Medical Oncology at Università Politecnica Marche; Director of Department of Medical Oncology, Director of the Postgraduate School of Oncology, Head of “Genetic Cancer” Laboratory, Deputy Director of Department of Clinical and Molecular Science, at Università Politecnica Marche, Ancona, Italy.

    Laura Cerchia, PhD

    Interests: aptamers; cell-SELEX; cancer theranostics; cell-surface receptors; tumor‐targeted drug delivery
    Research Scientist, Group Leader, Institute of Experimental Endocrinology and Oncology "G. Salvatore" (IEOS), National Research Council (CNR), Naples, Italy

    Eyad Elkord, PhD

    Interests: tumor immunology; cancer immunotherapy; immunosuppression; T regulatory cells; cancer epigenetics
    Principal Investigator and Professor, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar; Honorary Professor, University of Manchester, UK

    Vanesa Gregorc, MD

    Interests: thoracic neoplasm; lung cancer; pleural mesothelioma; thymus cancer; immuno-oncology
    Thoracic Oncology, Head and Neck and Melanoma Area Coordinator, IRCSS Scientific Institute, University Hospital San Raffaele, Milan, Italy

    Valentina Guarneri, MD

    Interests: breast cancer; acute myeloid leukemia; HER2-posite breast cancer; videos breast cancer
    Associate Professor of Oncology, University of Padua, Padua, Italy

    Sudeep Gupta, MD

    Interests: breast cancer; gynecological cancer; clinical trials
    Professor of Medical Oncology, Director, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, India

    Weilin Jin, MD, PhD

    Interests: brain tumors; cancer stem cells; epigenetics in cancer biology; cancer immunotherapy
    Associated Professor, School of Science and Techology, Shanghai Jiao Tong University, Shanghai, China

    Richard Kornbluth, MD, PhD

    Interests: dendritic cells; TNF superfamily ligands; CD40 ligand; 4-1BB ligand; latent membrane protein-1 (LMP1)
    Professor, Vaccine Research Institute of San Diego; CEO, Multimeric Biotherapeutics, Inc., San Diego, USA

    Ajaikumar Kunnumakkara, PhD

    Interests: cancer; inflammation; drug discovery; targeted delivery of drugs; discovery of novel targets
    Professor, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam, India